{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:01:46Z","timestamp":1764936106443,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K18754"],"award-info":[{"award-number":["19K18754"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.anl.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:34:35Z","timestamp":1699616075000},"page":"313-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-1054","authenticated-orcid":false,"given":"Nayuta","family":"Tsushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako C.","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8208-4118","authenticated-orcid":false,"given":"Seijiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Idogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-4617","authenticated-orcid":false,"given":"Yuji","family":"Nakamaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-0317","authenticated-orcid":false,"given":"Masanobu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-0646","authenticated-orcid":false,"given":"Akihiro","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2023.10.002_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/CMR.0b013e32834b58cf","article-title":"Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors","volume":"21","author":"Papaspyrou","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.anl.2023.10.002_bib0002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MOO.0000000000000428","article-title":"Updates in the management of sinonasal mucosal melanoma","volume":"26","author":"Crippen","year":"2018","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2023.10.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1190-3","article-title":"MiR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy","volume":"38","author":"Tang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.10.002_bib0004","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/lary.29574","article-title":"Surgical margin status and survival following resection of sinonasal mucosal melanoma","volume":"131","author":"Elsamna","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2023.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hed.24435","article-title":"Localized sinonasal mucosal melanoma: outcomes and associations with stage, radiotherapy, and positron emission tomography response","volume":"38","author":"Samstein","year":"2016","journal-title":"Head Neck"},{"year":"2023","series-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines): head and neck cancers (Version 2.2023)","key":"10.1016\/j.anl.2023.10.002_bib0006"},{"key":"10.1016\/j.anl.2023.10.002_bib0007","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anl.2020.06.014","article-title":"The role of endoscopic resection for selected patients with sinonasal squamous cell carcinoma","volume":"48","author":"Nakamaru","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2023.10.002_bib0008","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s12325-022-02080-x","article-title":"The selective role of open and endoscopic approaches for sinonasal malignant tumours","volume":"39","author":"L\u00f3pez","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.anl.2023.10.002_bib0009","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s10147-023-02368-0","article-title":"Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy","volume":"28","author":"Tsushima","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.anl.2023.10.002_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680407","article-title":"Immunotherapy in acral and mucosal melanoma: current status and future directions","volume":"12","author":"Mao","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.anl.2023.10.002_bib0011","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anl.2023.10.002_bib0012","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jop.12849","article-title":"CD117 immunoexpression in oral and sinonasal mucosal melanoma does not correlate with somatic driver mutations in the MAPK pathway","volume":"48","author":"Maldonado-Mendoza","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.anl.2023.10.002_bib0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.2013.373","article-title":"KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases","volume":"109","author":"Zebary","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anl.2023.10.002_bib0014","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1078-0432.CCR-11-1987","article-title":"Sunitinib therapy for melanoma patients with KIT mutations","volume":"18","author":"Minor","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.10.002_bib0015","doi-asserted-by":"crossref","first-page":"E1737","DOI":"10.1002\/hed.24309","article-title":"Sinonasal mucosal melanoma: a 12-year experience of 58 cases","volume":"38","author":"Lombardi","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2023.10.002_bib0016","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anl.2023.10.002_bib0017","article-title":"Association of NRAS mutation with clinical outcomes of anti-PD-1 monotherapy in advanced melanoma: a pooled analysis of four asian clinical trials","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.anl.2023.10.002_bib0018","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/imt-2018-0030","article-title":"A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a Chinese population","volume":"11","author":"Zhang","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.anl.2023.10.002_bib0019","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.2014.287","article-title":"Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma","volume":"111","author":"Carlino","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anl.2023.10.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081133","article-title":"Atypical BRAF and NRAS mutations in mucosal melanoma","volume":"11","author":"Dumaz","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2023.10.002_bib0021","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anl.2023.10.002_bib0022","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.22.02018","article-title":"Initial evidence for the efficacy of naporafenib in combination with trametinib in NRAS-mutant melanoma: results from the expansion arm of a phase Ib, open-label study","volume":"41","author":"de Braud","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2023.10.002_bib0023","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.anl.2023.10.002_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/\u03b2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.anl.2023.10.002_bib0025","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear \u03b2-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anl.2023.10.002_bib0026","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.anl.2023.10.002_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.anl.2023.10.002_bib0028","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.annonc.2020.05.031","article-title":"Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients","volume":"31","author":"Nakamura","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2023.10.002_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1349-7006.2003.tb01424.x","article-title":"Tumor formation by genetic mutations in the components of the Wnt signaling pathway","volume":"94","author":"Kikuchi","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2023.10.002_bib0030","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2023.10.002_bib0031","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.21037\/tcr-20-1871","article-title":"Mutational profiling of melanomas in patients from the southeast coast of China","volume":"9","author":"Zheng","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.anl.2023.10.002_bib0032","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41379-022-01122-7","article-title":"Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature","volume":"35","author":"Ch\u0142opek","year":"2022","journal-title":"Mod Pathol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814623001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:40:15Z","timestamp":1759952415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814623001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0385814623001839"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2023.10.002","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}